Cassava Sciences faces increased scrutiny of Alzheimer's drug, presses ahead with advanced trials

Published on 19 Nov 2021 on American City Business Journals

Austin-based biopharmaceutical company Cassava Sciences Inc. has attracted the attention of...

Read the rest of the article

Start tracking your investments with Statfolio

In this article, we discuss 14 dividend growth stocks with highest growth rates. You can skip our...

Insider Monkey via Yahoo Finance 24 Apr 2024

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 23 Apr 2024

Eli Lilly and Company, the pharmaceutical giant, has finalized the acquisition of a production...

WISN 12 Milwaukee 22 Apr 2024

Eli Lilly and Company LLY announced that its pipeline candidate, tirzepatide, met all primary and...

Zacks via Yahoo Finance 18 Apr 2024

Eli Lilly and Company (LLY) shares rose 0.5% after announcing positive late-stage results for its...

Zacks via Yahoo Finance 18 Apr 2024

In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our...

Insider Monkey via Yahoo Finance 18 Apr 2024

Eli Lilly's semaglutide-based drugs for diabetes and weight loss, Mounjaro and Zepbound, will fac...

Seeking Alpha 17 Apr 2024

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea,...

CNN.com 17 Apr 2024

From the ongoing conflict between Israel and Hamas, to UEFA Champions League quarter finals, to t...

dpa international via Yahoo News 12 Apr 2024

Barclays cites implications for the biopharma sector after a mid-stage trial showed that the GLP-...

Seeking Alpha 12 Apr 2024